A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle
- PMID: 8892954
- PMCID: PMC190903
- DOI: 10.1128/JVI.70.11.8204-8208.1996
A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle
Abstract
In Epstein-Barr virus (EBV)-associated tumors that arise in immunocompetent individuals, the pattern of viral gene expression is very restricted compared with that of latently infected B cells in tissue culture. A hallmark of viral gene expression in these tumors is the exclusive expression of only one EBV-encoded nuclear antigen, EBNA1, which is driven from a promoter (Qp) that lies near the junction of the viral BamHI F and Q fragments. During induction of the lytic cycle, a viral promoter, Fp, which lies ca. 200 bp upstream of Qp, gives rise to transcripts which overlap with Qp-initiated EBNA1 gene transcripts. Distinguishing between latency-associated EBNA1 gene transcripts and those associated with the early phase of the viral lytic cycle is critical for correct identification of restricted viral latency. Here we describe a reverse transcriptase PCR protocol which employs a nested set of upstream primers from the BamHI Q region of the viral genome and readily distinguishes Fp-initiated transcripts from Qp-initiated transcripts. A single set of amplification conditions was used for the various PCR primer combinations, which allowed all reactions to be run simultaneously. An in vitro-generated transcript, diluted in RNA from an EBV-negative cell line, was used to demonstrate that the efficiencies of amplification with the different primer combinations were very similar. This protocol was used to demonstrate that EBNA1 gene transcription in two previously uncharacterized EBV-positive epithelial cell lines initiates from Qp. In addition, we assessed the site(s) of initiation of EBNA1 gene transcripts in cell lines exhibiting restricted viral latency. Contrary to the results of Nonkwelo et al. (J. Virol. 70:623-627, 1996), which indicated that EBNA1 gene transcription during restricted viral latency initiates at multiple sites downstream of Fp, we show here that nearly all EBNA1 transcripts start at the previously identified Qp transcription initiation site.
Similar articles
-
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992. J Virol. 1992. PMID: 1331531 Free PMC article.
-
Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.J Gen Virol. 1999 Feb;80 ( Pt 2):457-466. doi: 10.1099/0022-1317-80-2-457. J Gen Virol. 1999. PMID: 10073708
-
Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.Mol Pathol. 2001 Apr;54(2):98-102. doi: 10.1136/mp.54.2.98. Mol Pathol. 2001. PMID: 11322171 Free PMC article.
-
Epigenetic regulation of latent Epstein-Barr virus promoters.Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):228-35. doi: 10.1016/j.bbagrm.2009.10.005. Epub 2009 Oct 22. Biochim Biophys Acta. 2010. PMID: 19853674 Review.
-
Epigenotypes of latent herpesvirus genomes.Curr Top Microbiol Immunol. 2006;310:61-80. doi: 10.1007/3-540-31181-5_5. Curr Top Microbiol Immunol. 2006. PMID: 16909907 Review.
Cited by
-
Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients.J Exp Med. 1999 Aug 16;190(4):567-76. doi: 10.1084/jem.190.4.567. J Exp Med. 1999. PMID: 10449527 Free PMC article.
-
Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.J Exp Med. 2003 Sep 15;198(6):903-11. doi: 10.1084/jem.20022058. J Exp Med. 2003. PMID: 12975456 Free PMC article.
-
The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.J Virol. 1998 Sep;72(9):7075-83. doi: 10.1128/JVI.72.9.7075-7083.1998. J Virol. 1998. PMID: 9696800 Free PMC article.
-
Kaposi sarcoma-associated herpesvirus cooperates with Epstein-Barr virus to co-transform a small set of human B cells oncogenically.PLoS Pathog. 2025 Jun 23;21(6):e1013281. doi: 10.1371/journal.ppat.1013281. eCollection 2025 Jun. PLoS Pathog. 2025. PMID: 40549805 Free PMC article.
-
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.Front Immunol. 2021 Nov 15;12:656797. doi: 10.3389/fimmu.2021.656797. eCollection 2021. Front Immunol. 2021. PMID: 34867935 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources